Established in 2008, the Evans School Policy Analysis and Research Group (EPAR) uses an innovative student-faculty team model to provide rigorous, applied research and analysis to international development stakeholders. EPAR has prepared more than 300 technical reports and briefs including: statistical data analysis and research, literature reviews and analysis, and portfolio analysis and strategy support. Our reports focus on agriculture, development policy, financial services, poverty reduction, gender, and measurement and evaluation.

Click on the links below to learn more about recent EPAR research and to explore EPAR's research in sustainable agriculture and rural livelihoods, household well-being and equity, development finance and policy, and technology, or follow the links above to learn more about EPAR, access research resources, explore interactive data visualizations, and read recent blog posts. Click here to subscribe to our mailing list and get regular updates on our research.

Browse EPAR Research

EPAR News

New EPAR Research

Agricultural Development Indicator Curation

EPAR has developed Stata do.files for the construction of a set of agricultural development indicators using data from the Living Standards Measurement Study - Integrated Surveys on Agriculture (LSMS-ISA) for Ethiopia, Nigeria, and Tanzania. Follow the link below to see initial indicator estimates and to access our indicator construction code and documentation.
Explore our research
EPAR Visualization
Ag R&D

Changes in Public Sector Agriculture R&D

How is public agricultural research investment allocated across Sub-Saharan Africa? Which crop production variables are associated with public allocations of agricultural researchers and research expenditures? How has this changd over time? Our new interactive dashboard allows users to explore how crop specific public agricultural research funding has changed over time in Sub-Saharan Africa.
Explore the visualization
New EPAR Research
Photo Credit: PATH/Evelyn Hockstein

Private Sector Global Health R&D Investment

EPAR reviewed the 2016 10-K forms submitted by U.S. pharmaceutical companies involved in global health R&D to analyze how these companies discuss the incentives and challenges to private sector global health R&D investment. We find that LMIC pricing, market competition, patents and licensing, and expedited review policies are commonly discussed factors influencing R&D investments. Follow the link below to learn more.
Explore our research